drugset
drugset / Trial / NCT01992523

Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )

NCT01992523 ↗

Phase 3 Completed 82 enrolled David Antoniucci A.R. CARD Onlus Foundation · collabAstraZeneca · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the Mashed Or Just Integral pill of TicagrelOr (MOJITO) study is to evaluate the superiority of Ticagrelor 180 mg LD mashed pill versus Ticagrelor 180 mg LD integral pill both orally administrated in decreasing residual platelet reactivity 1 hour after the administration among 70 patients with STEMI (ST segment elevation myocardial infarction) undergoing PPCI (primary percutaneous coronary intervention) with bivalirudin monotherapy.

Timeline

Start
2013-11
Primary completion
2014-03
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ticagrelor Small molecule 180 mg Oral

Indications

acute coronary syndrome